IL2 and in situ carcinoma: Although the findings reported here may not fully reflect the direct relationship between CIS and DUSP4 and the negative regulation of IL-2 signaling in NK cells, their upregulation may be a noteworthy observation in an effort to regulate inappropriate or excessive activation of NK cells.